In Vivo And In Vitro Study on Antioxidant Activity Of Methanolic Extract Of Cryptostegia Grandiflora Leaves In Experimental Animals
Main Article Content
Abstract
This study evaluates the antioxidant and anticancer activities of the methanolic extract of Cryptostegia grandiflora leaves (CGME) using both in vitro and in vivo models. The antioxidant potential was assessed through DPPH radical scavenging in vitro and through various enzymatic assays in an animal model. Instrumental analysis such as Column Chromatography, UV, HPTLC, GCMS, and 1H NMR were utilized for compound identification. The results showed that CGME exhibited significant antioxidant activity in the DPPH assay and increased the levels of antioxidant enzymes, including SOD, CAT, GRD, GPX, and GST, while reducing LPO levels in vivo. These findings suggest that CGME has potential as a natural antioxidant with anticancer properties. Further studies are warranted to explore its mechanisms of action and therapeutic potential.
Article Details
References
Smith, J., & Brown, A. (2019). Antioxidant and anticancer properties of Apocynaceae family plants. Journal of Medicinal Plants Research, 13(4), 145-156.
Kumar, P., & Singh, R. (2020). Phytochemical screening and pharmacological activities of Cryptostegia grandiflora. Journal of Pharmacognosy and Phytochemistry, 9(3), 678-682.
Miller, A. L. (2018). Free radicals and antioxidants in human health. Clinical Nutrition, 27(2), 179-193.
Sharma, V., & Gupta, S. (2021). Authentication of medicinal plants. Journal of Herbal Medicine, 12(1), 55-60.
Blois, M. S. (1958). Antioxidant determinations by the use of a stable free radical. Nature, 181, 1199-1200.
Kakkar, P., Das, B., & Viswanathan, P. N. (1984). A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry & Biophysics, 21(2), 130-132.
Patil, R. H., & Shinde, R. N. (2023). Instrumental analysis for phytochemical studies. Journal of Analytical Chemistry, 18(3), 203-211.
Singh, N., & Rajput, R. (2022). Therapeutic potential of natural antioxidants in chronic diseases. Current Pharmaceutical Design, 28(4), 535-548.
